Kidney Research and Clinical Practice

Search

Page Path

HOME
Search

Review Article

The pathophysiological significance between autosomal dominant polycystic kidney disease and neutrophil gelatinase-associated lipocalin: Pallavi Devapatla, Wen-Yih Jeng, Wen-Tai Chiu, Hsiu Mei Hsieh-Li; Kidney Res Clin Pract. 2025;44(2):238-248. Published online March 12, 2025; DOI: https://doi.org/10.23876/j.krcp.23.339
Web of Science 2 Cited By 2; Full text PubReader ePub PDF

Original Articles

Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): final report: Hayne Cho Park, Yong Chul Kim, Hyunsuk Kim et al.; Kidney Res Clin Pract. 2026;45(2):220-231. Published online September 11, 2024; DOI: https://doi.org/10.23876/j.krcp.24.067
Web of Science 1; Full text PubReader ePub PDF Supplementary Material

Baseline characteristics of the Korean genetic cohort of inherited cystic kidney disease: Jeong Min Cho, Hayne Cho Park, Jin Woo Lee et al.; Kidney Res Clin Pract. 2023;42(5):617-627. Published online September 27, 2023; DOI: https://doi.org/10.23876/j.krcp.23.097
Web of Science 1 Cited By 2; Full text PubReader ePub PDF Supplementary Material

Identification of osteopontin as a urinary biomarker for autosomal dominant polycystic kidney disease progression: Hyunsuk Kim, Jinmo Sung, Ju Young Bae, Poongyeon Lee, Yun Kyu Oh, Hyunho Kim; Kidney Res Clin Pract. 2022;41(6):730-740. Published online June 20, 2022; DOI: https://doi.org/10.23876/j.krcp.21.303
Web of Science 13 Cited By 14; Full text PubReader ePub PDF

Review Articles

Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options: Yeshwanter Radhakrishnan, Parikshit Duriseti, Fouad T. Chebib; Kidney Res Clin Pract. 2022;41(4):422-431. Published online March 29, 2022; DOI: https://doi.org/10.23876/j.krcp.21.309
Web of Science 18 Cited By 23; Full text PubReader ePub PDF

Original Articles

Mayo imaging classification is a good predictor of rapid progress among Korean patients with autosomal dominant polycystic kidney disease: results from the KNOW-CKD study: Hayne Cho Park, Yeji Hong, Jeong-Heum Yeon et al.; Kidney Res Clin Pract. 2022;41(4):432-441. Published online March 3, 2022; DOI: https://doi.org/10.23876/j.krcp.21.261
Web of Science 12 Cited By 14; Full text PubReader ePub PDF Supplementary Material

Comparison of chronic kidney disease trial designs and analysis strategies: John Lawrence; Kidney Res Clin Pract. 2021;40(1):62-68. Published online March 5, 2021; DOI: https://doi.org/10.23876/j.krcp.20.104
Web of Science 2 Cited By 3; Full text PubReader ePub PDF Supplementary Material

PKD2 mutation in an Iranian autosomal dominant polycystic kidney disease family with misleading linkage analysis data^☆: Mona Entezam, Mohammad Reza Khatami, Fereshteh Saddadi, Mohsen Ayati, Jamshid Roozbeh, Mohammad Keramatipour; Kidney Res Clin Pract. 2016;35(2):96-101. Published online February 27, 2016; DOI: https://doi.org/10.1016/j.krcp.2016.02.003
Web of Science 2 Cited By 2; Full text PubReader PDF

Review Article

Cyst growth, polycystins, and primary cilia in autosomal dominant polycystic kidney disease: Seung Hun Lee, Stefan Somlo; Kidney Res Clin Pract. 2014;33(2):73-78. Published online June 14, 2014; DOI: https://doi.org/10.1016/j.krcp.2014.05.002
Web of Science 42 Cited By 40; Full text PubReader PDF

A Case of Spontaneous Subdural Hematoma in a Patient with Autosomal Dominant Polycystic Kidney Disease: Won Ik Jang, M.D., Young Rok Ham, M.D., Ji Yoon Jung, M.D., Dong Suk Chang, M.D., Sarah Chung, M.D., Dae Eun Choi, M.D., Ki Ryang Na, M.D., Kang Wook Lee, M.D. and Young Tai Shin, M.D.; Korean J Nephrol. 2010;29(6):802-806.; PDF

Tuberous Sclerosis Manifested by Spontaneous Rupture of Renal Angiomyolipoma in a Patient with Polycystic Kidney Disease: Tae-Woo Kim, M.D. Sook Kim, M.D. , Seung Boo Yang, M.D. Chu Hee Lee, Ph.D. Jun Young Do, M.D. Jong Won Park, M.D.; Korean J Nephrol. 2007;26(6):772-778.; PDF

Volume 45, No. 4

Kidney Research
and
Clinical Practice

Print ISSN: 2211-9132
Online ISSN: 2211-9140

Impact Factor

3.5

MOST VIEWED MOST CITED

55,217	Factors associated with gait speed: results from the RolE of AST120 (Renamezin) in sarCOpenia preVEntion in pRe-dialYsis chronic kidney disease patients (RECOVERY) study
33,241	The burden of chronic kidney disease in Asia region: a review of the evidence, current challenges, and future directions
9,433	Baseline characteristics and associated factors for hypertension in children with chronic kidney disease: results from the Korean Cohort Study for Outcome in Patients with Pediatric Chronic Kidney Disease study
9,205	Role of urate transporters in the kidneys and intestine in uric acid homeostasis
14,857	Management of high-flow arteriovenous access

Cited By 23	The burden of chronic kidney disease in Asia region: a review of the evidence, current challenges, and future directions
Cited By 18	Kidney Health Plan 2033 in Korea: bridging the gap between the present and the future
Cited By 17	Pathogenesis and management of renal fibrosis induced by unilateral ureteral obstruction
Cited By 16	Sarcopenia, sarcopenic obesity, and frailty in individuals with chronic kidney disease: a comprehensive review
Cited By 15	Artificial intelligence and machine learning’s role in sepsis-associated acute kidney injury

Editorial Office: #301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736 Fax: +82-2-3486-8737 E-mail: registry@ksn.or.kr

Copyright © 2026 by The Korean Society of Nephrology.